The following treatments are typically recommended: * Intravaginal (vaginal suppository): butoconazole, clotrimazole, miconazole, nystatin, tioconazole, terconazole. Candidal vulvovaginitis in pregnancy should be treated with intravaginal clotrimazole or nystatin for at<unk>  7 days. All are more or less equally effective. * By mouth: ibrexafungerp, fluconazole as a single dose. For severe disease another dose after 3 days may be used. Short-course topical formulations (i.e., single dose and regimens of 1–3 days) effectively treat uncomplicated candidal vulvovaginitis. The topically applied azole drugs are more effective than nystatin. Treatment with azoles results in relief of symptoms and negative cultures in 80–90% of patients who complete therapy. The creams and suppositories in this regimen are oil-based and might weaken latex condoms and diaphragms. Treatment for vagina thrush using antifungal medication is ineffective in up to 20% of cases. Treatment for thrush is considered to have failed if the symptoms do not clear within 7–14 days. There are a number of reasons for treatment failure. For example, if the<unk>  is a different kind, such as bacterial vaginosis (the most common cause of abnormal vaginal discharge), rather than thrush. Recurrent For infrequent recurrences, the simplest and most cost-effective management is self-diagnosis and early initiation of topical therapy. However, women whose condition has previously been diagnosed with candidal vulvovaginitis are not necessarily more likely to be able to diagnose themselves; therefore, any woman whose symptoms persist after using an over the counter preparation, or who has a recurrence of symptoms within two months, should be evaluated with office-based testing. Unnecessary or inappropriate use of topical preparations is common and can lead to a delay in the treatment of other causes of vulvovaginitis, which can result in worse outcomes. When there are more than four recurrent episodes of candidal vulvovaginitis per year, a longer initial treatment course is recommended, such as orally administered fluconazole followed by a second and third dose 3 and 6 days later, respectively. Other treatments after more than four episodes per year, may include ten days of either oral or topical treatment followed by fluconazole orally once per week for six months. About 10-15% of recurrent candidal vulvovaginitis cases are due to non-Candida albicans species. Non-albicans species tend to have higher levels of resistance to fluconazole. Therefore, recurrence or persistence of symptoms while on treatment indicates speciation and antifungal resistance tests to tailor antifungal treatment. Alternative medicine Up to 40% of women seek alternatives to treat<unk> . Example products are herbal preparations, probiotics and vaginal acidifying agents. Other alternative treatment approaches include switching contraceptive, treatment of the sexual partner and gentian violet. However, the effectiveness of such treatments has not received much study. Probiotics (either as pills or as yogurt) do not appear to decrease the rate of occurrence of<unk> s. No benefit has been found for active<unk> s. Example probiotics purported to treat and prevent candida<unk> s are Lactobacillus fermentum RC-14, Lactobacillus fermentum B-54, Lactobacillus rhamnosus GR-1, Lactobacillus rhamnosus GG and Lactobacillus acidophilus. There is no evidence to support the use of special cleansing diets and colonic hydrotherapy for prevention.
Vaginal yeast infection
Bacterial vaginosis
Chlamydia
Atrophic vaginitis
Gonorrhea
Aerobic vaginitis
Vaginal intraepithelial neoplasia
Puberty menorrhagia